Ra Medical Systems RMED

$ 0.59 10.0%

Quarterly report 2024-Q2
added 08-14-2024

Ra Medical Systems Balance Sheet 2011-2024 | RMED

Annual Balance Sheet Ra Medical Systems

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-12.8 M	-21.6 M	-14 M	-63.5 M	-	-	-	-	-	-	-
Long Term Debt	-	1.98 M	1.58 M	265 K	557 K	-	-	-	-	-	-	-
Long Term Debt Current	-	283 K	356 K	318 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	4.53 M	4.12 M	1.38 M	-	-	-	-	-	-	-
Total Current Liabilities	7.58 M	5.39 M	7.76 M	6.81 M	5.95 M	-	-	-	-	-	-	-
Total Liabilities	7.58 M	7.37 M	12.3 M	10.9 M	7.33 M	-	-	-	-	-	-	-
Deferred Revenue	-	-	1.8 M	2.03 M	1.72 M	-	-	-	-	-	-	-
Retained Earnings	-205 M	-178 M	-	-117 M	-60.2 M	-	-	-	-	-	-	-
Total Assets	16.8 M	21 M	33.4 M	44.1 M	74 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	15.9 M	15 M	23.9 M	14.6 M	64.3 M	8.24 M	-	-	-	-	-	-
Book Value	9.26 M	13.7 M	21.1 M	33.2 M	66.7 M	-	-	-	-	-	-	-
Total Shareholders Equity	9.26 M	13.7 M	21.1 M	33.2 M	66.7 M	-7.62 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Ra Medical Systems

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	62 K	87 K	97 K	121 K	144 K	88 K	-	1.75 M	1.83 M	1.9 M	1.98 M	2.05 M	2.12 M	2.2 M	2.26 M	2.26 M	2.26 M	2.26 M	558 K	2.62 M	2.62 M	2.62 M	850 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	11.9 M	9.5 M	9.54 M	11 M	11.8 M	12.6 M	7.58 M	4.96 M	4.58 M	5.64 M	7.37 M	5.53 M	7.9 M	10.1 M	12.3 M	12.3 M	12.3 M	12.3 M	10.9 M	10.9 M	10.9 M	10.9 M	7.33 M	7.33 M	7.33 M	7.33 M	18.9 M	18.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	1.79 M	1.78 M	1.8 M	1.73 M	1.86 M	1.8 M	2.03 M	2.03 M	2.03 M	2.03 M	1.72 M	1.75 M	1.72 M	1.72 M	1.71 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-283 M	-278 M	-276 M	-275 M	-273 M	-272 M	-205 M	-197 M	-192 M	-184 M	-178 M	-170 M	-166 M	-160 M	-153 M	-153 M	-153 M	-153 M	-117 M	-117 M	-117 M	-117 M	-60.2 M	-60.2 M	-60.2 M	-60.2 M	-29.4 M	-29.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	26.3 M	28 M	30.7 M	32.9 M	35.5 M	48.5 M	16.8 M	17.5 M	14.4 M	23.7 M	21 M	27.1 M	29.2 M	25.3 M	33.4 M	33.4 M	33.4 M	33.4 M	44.1 M	44.1 M	44.1 M	44.1 M	74 M	74 M	74 M	74 M	11.3 M	11.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	16 K	1.49 M	3.56 M	5.58 M	7.41 M	12.2 M	15.9 M	13.7 M	11.1 M	17.7 M	15 M	20.6 M	20.2 M	16 M	23.9 M	23.9 M	23.9 M	23.9 M	14.6 M	14.6 M	14.6 M	14.6 M	64.3 M	64.3 M	64.3 M	64.3 M	8.24 M	8.24 M	-	-	3.92 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	14.3 M	18.5 M	21.2 M	21.9 M	23.8 M	35.9 M	9.26 M	12.5 M	9.79 M	18.1 M	13.7 M	21.5 M	21.3 M	15.1 M	21.1 M	21.1 M	21.1 M	21.1 M	33.2 M	33.2 M	33.2 M	33.2 M	66.7 M	66.7 M	66.7 M	66.7 M	-7.62 M	-7.62 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	14.3 M	18.5 M	21.2 M	21.9 M	23.8 M	35.9 M	9.26 M	12.5 M	9.79 M	18.1 M	13.7 M	21.5 M	21.3 M	15.1 M	21.1 M	21.1 M	21.1 M	21.1 M	33.2 M	33.2 M	33.2 M	33.2 M	66.7 M	66.7 M	66.7 M	66.7 M	-7.62 M	-7.62 M	-	-	-380 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency